West Pharmaceutical Services (WST) financials
West Pharmaceutical Services revenue and earnings by year
West Pharmaceutical Services's revenue was $3.07 billion in the fiscal year to December 31, 2025, up 6.3% from the year before. Net income was $494 million, 16.1% of revenue. Since the fiscal year to December 31, 2016, revenue has grown 8.2% a year on average.
Fiscal years, each labelled by the calendar year it ended in.
Income statement, the last 10 fiscal years
| Fiscal year to | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 3.07 | 2.89 | 2.95 | 2.89 | 2.83 | 2.15 | 1.84 | 1.72 | 1.60 | 1.51 |
| Revenue growth | 6.3% | -1.9% | 2.2% | 2.0% | 31.9% | 16.7% | 7.1% | 7.4% | 6.0% | — |
| Gross profit | 1.10 | 1.00 | 1.13 | 1.14 | 1.18 | 0.77 | 0.61 | 0.55 | 0.51 | 0.50 |
| Gross margin | 35.9% | 34.5% | 38.3% | 39.4% | 41.5% | 35.8% | 32.9% | 31.8% | 32.1% | 33.2% |
| Operating income | 0.58 | 0.57 | 0.68 | 0.73 | 0.75 | 0.41 | 0.30 | 0.24 | 0.23 | 0.20 |
| Operating margin | 19.0% | 19.7% | 22.9% | 25.4% | 26.6% | 19.0% | 16.1% | 14.0% | 14.2% | 12.9% |
| Net income | 0.49 | 0.49 | 0.59 | 0.59 | 0.66 | 0.35 | 0.24 | 0.21 | 0.15 | 0.14 |
| Net margin | 16.1% | 17.0% | 20.1% | 20.3% | 23.4% | 16.1% | 13.1% | 12.0% | 9.4% | 9.5% |
| Diluted EPS | $6.79 | $6.69 | $7.88 | $7.73 | $8.67 | $4.58 | $3.20 | $2.74 | $1.99 | $1.91 |
| Free cash flow | 0.47 | 0.28 | 0.41 | 0.44 | 0.33 | 0.30 | 0.24 | 0.18 | 0.13 | 0.05 |
Diluted EPS is stated in today's shares (adjusted for every split since). Quarterly statements and the income statement as a flow chart are in the app: open WST in Markets.
How West Pharmaceutical Services makes money
Revenue by segment in the quarter to September 30, 2026, as the company reports it.
| Segment | Revenue | Share |
|---|---|---|
| Proprietary Products | $729M | 83.3% |
| West Vantage | $146M | 16.7% |
See also: WST valuation and P/E history · WST returns
No forecast, no recommendation. This page describes West Pharmaceutical Services from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.